Less invasive surfactant therapies (LIST) use surfactant instillation through a thin tracheal
catheter in spontaneously breathing infants. This review and meta-analysis investigates …

Bronchopulmonary dysplasia (BPD) remains the most prevalent long-term morbidity of
surviving extremely preterm infants and is associated with significant health care utilization …

Less invasive surfactant administration or minimally invasive surfactant therapy (LISA/MIST)
has been proposed for the administration of surfactant in preterm infants without intubation …

In a large cohort study of the German Neonatal Network (GNN) we aimed to evaluate
whether less invasive surfactant administration (LISA) strategy is associated with …

Preterm neonates with respiratory distress syndrome (RDS) are commonly treated with
surfactant by intubate surfactant extubate (InSurE) technique. Mode of surfactant …

Background The majority of extremely low gestational age neonates undergo intubation for
surfactant therapy. Less invasive surfactant administration (LISA) uses a thin catheter …

Exogenous surfactant replacement is the most effective evidence-based therapy for
respiratory distress syndrome in preterm infants. The mode of administration has evolved in …

Neonatal respiratory distress syndrome due to surfactant deficiency is associated with high
morbidity and mortality in preterm infants, and the use of less invasive surfactant …

Objective To evaluate incidence of minimally invasive surfactant therapy (MIST) failure,
identify risk factors and assess the impact of MIST failure on neonatal outcome. Design …

Respiratory distress syndrome (RDS) was recognized to be caused by primary surfactant
deficiency almost 70 years ago and continuous positive airway pressure was introduced …